University of Liverpool: New Discovery Could Help Treat a Rare and Severe Form of Amyloidosis
July 11, 2024
July 11, 2024
LIVERPOOL, England, July 11 (TNSres) -- The University of Liverpool issued the following news release:
In people with a rare condition called light chain amyloidosis, light chain proteins--which are a component of antibodies--mutate and build up in different organs.
In new research published in The FEBS Journal, researchers from the University of Liverpool have identified and characterized an antibody fragment that can bind to abnormal light chains to stabilize them and . . .
In people with a rare condition called light chain amyloidosis, light chain proteins--which are a component of antibodies--mutate and build up in different organs.
In new research published in The FEBS Journal, researchers from the University of Liverpool have identified and characterized an antibody fragment that can bind to abnormal light chains to stabilize them and . . .